BRC’s signature anti-aging approach restores the endocrine system at the source. We combine your own regenerative cells with organ-specific peptides to rejuvenate hormone-producing glands so the body can resume natural hormone production.
Regenerative cell therapy with organ-specific peptides is BRC’s core anti-aging method. Rather than relying on synthetic replacement, we aim to restore the natural function of endocrine glands that produce hormones.
This dual therapy uses your own mesenchymal stem cells together with targeted signaling peptides to rejuvenate thyroid, thymus, adrenal glands, pituitary, pineal gland, testes, and ovaries.
Endocrine targets
Address aging at the source by supporting the organs that make hormones.
Two synergistic modalities operate together: your cells provide regenerative capacity and organ peptides provide functional direction.
MSCs from bone marrow or adipose can home to endocrine organs, reduce inflammation, and stimulate tissue repair to restore function that has declined with age.
Targeted peptides are selected for thyroid, thymus, adrenal, pituitary, pineal, testes, and ovaries to enhance signaling for metabolism, immune resilience, stress response, reproductive balance, and growth axis support.
Harvest and concentrate cells, then administer by IV so they circulate to areas of need while organ peptides deliver precise signals. The aim is to help organs resume natural production, lowering dependence on replacement.
Natural restoration of energy and vitality as thyroid and adrenal function improves, with better stress resilience and cortisol balance.
Metabolic efficiency, easier weight management, and immune support via thymus rejuvenation. Potential improvement in growth hormone pathways through pituitary support.
Reproductive balance: support for testosterone in men and estrogen or progesterone balance in women. Additional gains can include sleep quality, tissue repair, and lean mass.
Broader effects: circadian rhythm support, better glucose metabolism, cognitive clarity, lower inflammation, and improved cardiovascular markers.
Timeline: initial gains often appear within 4 to 8 weeks with progressive benefits across 3 to 6 months as organ regeneration advances. Some may still need partial supplementation.
Arc varies with baseline status and adherence to care.
Autologous cells minimize rejection risk. Peptides are bioidentical to natural signals with low adverse event rates. Minimal downtime. We coordinate with your clinicians and monitor labs
Detailed hormone panels and organ function review to set goals and select organ peptides.
Harvest and concentrate MSCs, then deliver by IV while administering targeted organ peptides.
Track hormone levels and symptoms over weeks to months, adjusting plan and supplementation as needed.
Ready to explore endocrine system restoration rather than simple hormone replacement?
Our comprehensive consultation evaluates your current endocrine function, identifies specific organ dysfunction, and determines your candidacy for regenerative cell therapy combined with targeted organ signaling peptides.
Please bring: Recent comprehensive hormone panels (thyroid, sex hormones, DHEA, IGF-1, cortisol), current medication list including any hormone therapy, detailed symptom history, medical records related to endocrine health.
Online Booking Available